Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results

Myriad Genetics (MYGN) Tops Q1 EPS by 13c

November 6, 2018 4:17 PM EST

Myriad Genetics (NASDAQ: MYGN) reported Q1 EPS of $0.43, $0.13 better than the analyst estimate of $0.30. Revenue for the quarter came in at $202.3 million versus the consensus estimate of $202.37 million.

GUIDANCE:

Myriad Genetics sees FY2019 EPS of $1.70-$1.75, versus the consensus of... More